Rhode Island MPJE Practice Exam 2025 – Complete Study Guide

Investigational drugs must be clearly identified and segregated from commercial products to ensure safety and compliance with regulatory standards. The label "For Investigational Use Only" is specifically designed for drugs that are still under investigation and have not been fully approved for general use. This labeling is crucial because it communicates to pharmacists and healthcare professionals that the drug is not yet available for general prescription and carries specific risks as it is part of a clinical study.

This clear distinction helps prevent inadvertent dispensing of investigational drugs as commercial medications, which could potentially lead to misuse or harmful patient outcomes. The label effectively informs all stakeholders, including pharmacists, that the drug's use is restricted and closely monitored within the confines of the investigation. Hence, identifying investigational drugs with this specific label plays a vital role in the integrity of clinical trials and patient safety.